Trial Details
Not recruitingBasic Information
| Clinical ID | c2152 |
|---|---|
| Identifier | NCT06055023 |
| Trial Title | Phase I Clinical Study on the Tolerability, Safety and Pharmacokinetics of Single-dose Dose Escalation and Multiple-dose Oral ZL-82 Tablets in Healthy Adult Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Rheumatoid Arthritis (RA);Inflammatory Bowel Disease - IBD1 |
| Interventions | Drug: ZL-82 12.5mg;Drug: ZL-82 25mg;Drug: ZL-82 50mg;Drug: ZL-82 100mg;Drug: ZL-82 200mg;Drug: ZL-82 300mg;Drug: ZL-82 450mg;Drug: ZL-82 600mg;Drug: zL-82 placebo 12.5mg;Drug: ZL-82 placebo 25mg;Drug: ZL-82 placebo 50mg;Drug: ZL-82 placebo 100mg;Drug: ZL-82 placebo 200mg;Drug: ZL-82 placebo 300mg;Drug: ZL-82 placebo 450mg;Drug: ZL-82 placebo 600mg |
Participant Information
| Sponsor | Chengdu Zenitar Biomedical Technology Co., Ltd |
|---|---|
| City | - |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |